12 Grants
2021
G-protein-, beta-arrestin- and ERK-signaling in alcohol use- and anxiety-disorders
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R01AA025368-05), $337,908USD, 2017-09-10 -- 2022-08-31
2020
G-protein-, beta-arrestin- and ERK-signaling in alcohol use- and anxiety-disorders
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R01AA025368-04), $338,120USD, 2017-09-10 -- 2022-08-31
2019
G-protein-, beta-arrestin- and ERK-signaling in alcohol use- and anxiety-disorders
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R01AA025368-03), $338,329USD, 09/10/2017 -- 08/31/2022
 
Opioidergic alkaloids from Mitragynia Speciosa (kratom) as novel treatment for alcohol use disorder
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R21AA026949-02), $221,951USD, 08/01/2018 -- 07/31/2020
2018
G-protein-, beta-arrestin- and ERK-signaling in alcohol use- and anxiety-disorders
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R01AA025368-02), $338,533USD, 09/10/2017 -- 08/31/2022
 
Opioidergic alkaloids from Mitragynia Speciosa (kratom) as novel treatment for alcohol use disorder
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 1R21AA026949-01), $199,524USD, 08/01/2018 -- 07/31/2020
2017
G-protein-, beta-arrestin- and ERK-signaling in alcohol use- and anxiety-disorders
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 1R01AA025368-01A1), $338,533USD, 09/10/2017 -- 08/31/2022
2015
Development of a preclinical candidate for the treatment of alcoholism
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R00AA020539-05), $237,370USD, 09/05/2013 -- 08/31/2016
2014
Development of a preclinical candidate for the treatment of alcoholism
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5R00AA020539-04), $241,531USD, 09/05/2013 -- 08/31/2016
2013
Development of a preclinical candidate for the treatment of alcoholism
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 4R00AA020539-03), $248,999USD, 09/05/2013 -- 08/31/2016
2012
Development of a preclinical candidate for the treatment of alcoholism
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 5K99AA020539-02), $88,419USD, 08/20/2011 -- 07/31/2013
2011
Development of a preclinical candidate for the treatment of alcoholism
Van Rijn, Richard M
National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA) (ID: 1K99AA020539-01), $90,000USD, 08/20/2011 -- 07/31/2013